XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Arcadia Wellness [Member]
August 2022 Offering [Member]
January 2021 PIPE [Member]
Common Stock [Member]
Common Stock [Member]
Arcadia Wellness [Member]
Common Stock [Member]
August 2022 Offering [Member]
Common Stock [Member]
January 2021 PIPE [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Arcadia Wellness [Member]
Additional Paid-In Capital [Member]
August 2022 Offering [Member]
Additional Paid-In Capital [Member]
January 2021 PIPE [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Non-Controlling Interest [Member]
Stockholders Equity, Beginning Balance at Dec. 31, 2020 $ 28,552       $ 54       $ 239,496       $ (211,825)   $ 827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020         13,450,861                    
Issuance of shares       $ 15,516       $ 8       $ 15,508      
Issuance of shares, Shares               7,876,784              
Offering costs       (2,084)               (2,084)      
Issuance of placement agent warrants       $ 942               $ 942      
Issuance of shares related to employee stock purchase plan 21               21            
Issuance of shares related to employee stock purchase plan, Shares         8,604                    
Stock-based compensation 325               325            
Non-controlling interest contributions 750                           750
Net income (loss) 1,681                       2,058   (377)
Stockholders Equity, Ending Balance at Mar. 31, 2021 45,703       $ 62       254,208       (209,767)   1,200
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2021         21,336,249                    
Stockholders Equity, Beginning Balance at Dec. 31, 2020 28,552       $ 54       239,496       (211,825)   827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020         13,450,861                    
Foreign currency translation adjustment (24)                            
Net income (loss) (6,577)                            
Stockholders Equity, Ending Balance at Sep. 30, 2021 40,223       $ 63       257,009       (217,203) $ (24) 378
Stockholders Equity, Ending Balance, Shares at Sep. 30, 2021         22,184,235                    
Stockholders Equity, Beginning Balance at Dec. 31, 2020 28,552       $ 54       239,496       (211,825)   827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020         13,450,861                    
Net income (loss) (16,100)                            
Stockholders Equity, Ending Balance at Dec. 31, 2021 31,196       $ 63       257,515       (226,485)   103
Stockholders Equity, Ending Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021 3,392               19,390       (15,998)    
Stockholders Equity, Ending Balance, Shares at Dec. 31, 2021         22,184,235                    
Stockholders Equity, Beginning Balance at Mar. 31, 2021 45,703       $ 62       254,208       (209,767)   1,200
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2021         21,336,249                    
Issuance of common stock at closing of acquisition transaction   $ 2,053       $ 1       $ 2,052          
Issuance of common stock at closing of acquisition transaction, Shares           827,401                  
Foreign currency translation adjustment (12)                         (12)  
Stock-based compensation 356               356            
Net income (loss) (5,422)                       (5,261)   (161)
Stockholders Equity, Ending Balance at Jun. 30, 2021 42,678       $ 63       256,616       (215,028) (12) 1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021         22,163,650                    
Issuance of shares related to employee stock purchase plan 17               17            
Issuance of shares related to employee stock purchase plan, Shares         6,585                    
Foreign currency translation adjustment (12)                         (12)  
Stock-based compensation 354               354            
Issuance of shares related to exercise of Service and Performance Warrants 22               22            
Issuance of shares related to exercise of Service and Performance Warrants, Shares         14,000                    
Net income (loss) (2,836)                       (2,175)   (661)
Stockholders Equity, Ending Balance at Sep. 30, 2021 40,223       $ 63       257,009       (217,203) $ (24) 378
Stockholders Equity, Ending Balance, Shares at Sep. 30, 2021         22,184,235                    
Stockholders Equity, Beginning Balance at Dec. 31, 2021 $ 31,196       $ 63       257,515       (226,485)   103
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2021         22,184,235                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                            
Issuance of shares related to employee stock purchase plan $ 4               4            
Issuance of shares related to employee stock purchase plan, Shares         4,683                    
Stock-based compensation 260               260            
Net income (loss) (4,610)                       (4,488)   (122)
Stockholders Equity, Ending Balance at Mar. 31, 2022 30,242       $ 63       277,169       (246,971)   (19)
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2022         22,188,918                    
Stockholders Equity, Beginning Balance at Dec. 31, 2021 31,196       $ 63       257,515       (226,485)   103
Stockholders Equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021 3,392               19,390       (15,998)    
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2021         22,184,235                    
Foreign currency translation adjustment (0)                            
Net income (loss) (11,284)                            
Stockholders Equity, Ending Balance at Sep. 30, 2022 25,019       $ 65       278,618       (253,615)   (49)
Stockholders Equity, Ending Balance, Shares at Sep. 30, 2022         24,642,960                    
Stockholders Equity, Beginning Balance at Mar. 31, 2022 30,242       $ 63       277,169       (246,971)   (19)
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2022         22,188,918                    
Stock-based compensation 323               323            
Net income (loss) (3,797)                       (3,777)   (20)
Stockholders Equity, Ending Balance at Jun. 30, 2022 26,768       $ 63       277,492       (250,748)   (39)
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2022         22,188,918                    
Issuance of shares     $ 1,176       $ 2       $ 1,174        
Issuance of shares, Shares             2,450,000                
Offering costs     $ (365)               $ (365)        
Issuance of shares related to employee stock purchase plan 3               3            
Issuance of shares related to employee stock purchase plan, Shares         4,042                    
Foreign currency translation adjustment (0)                            
Stock-based compensation 314               314            
Net income (loss) (2,877)                       (2,867)   (10)
Stockholders Equity, Ending Balance at Sep. 30, 2022 $ 25,019       $ 65       $ 278,618       $ (253,615)   $ (49)
Stockholders Equity, Ending Balance, Shares at Sep. 30, 2022         24,642,960